A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Clinical trial NCT04578548 · TERMINATED
Trial details
- NCT number
- NCT04578548
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2022-12-14
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.